CKPT
Price
$3.36
Change
+$0.06 (+1.82%)
Updated
Nov 6, 04:00 PM (EDT)
CYTK
Price
$54.93
Change
+$2.41 (+4.59%)
Updated
Nov 6, 04:00 PM (EDT)
Earnings call today
Ad is loading...

CKPT vs CYTK

Header iconCKPT vs CYTK Comparison
Open Charts CKPT vs CYTKBanner chart's image
Checkpoint Therapeutics
Price$3.36
Change+$0.06 (+1.82%)
Volume$69.93K
CapitalizationN/A
Cytokinetics
Price$54.93
Change+$2.41 (+4.59%)
Volume$230.87K
CapitalizationN/A
View a ticker or compare two or three
CKPT vs CYTK Comparison Chart
Loading...
CKPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CKPT vs. CYTK commentary
Nov 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CKPT is a Hold and CYTK is a Hold.

COMPARISON
Comparison
Nov 07, 2024
Stock price -- (CKPT: $3.30 vs. CYTK: $52.52)
Brand notoriety: CKPT and CYTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CKPT: 154% vs. CYTK: 102%
Market capitalization -- CKPT: $148.56M vs. CYTK: $6.18B
CKPT [@Biotechnology] is valued at $148.56M. CYTK’s [@Biotechnology] market capitalization is $6.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $488.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CKPT’s FA Score shows that 0 FA rating(s) are green whileCYTK’s FA Score has 1 green FA rating(s).

  • CKPT’s FA Score: 0 green, 5 red.
  • CYTK’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than CKPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CKPT’s TA Score shows that 5 TA indicator(s) are bullish while CYTK’s TA Score has 2 bullish TA indicator(s).

  • CKPT’s TA Score: 5 bullish, 5 bearish.
  • CYTK’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CKPT is a better buy in the short-term than CYTK.

Price Growth

CKPT (@Biotechnology) experienced а -14.06% price change this week, while CYTK (@Biotechnology) price change was +1.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.70%. For the same industry, the average monthly price growth was +12.96%, and the average quarterly price growth was +11.17%.

Reported Earning Dates

CKPT is expected to report earnings on May 15, 2023.

CYTK is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($6.18B) has a higher market cap than CKPT($149M). CKPT YTD gains are higher at: 44.105 vs. CYTK (-37.094). CKPT has higher annual earnings (EBITDA): -35.49M vs. CYTK (-459.67M). CYTK has more cash in the bank: 1.06B vs. CKPT (4.95M). CKPT has less debt than CYTK: CKPT (2.47M) vs CYTK (790M). CYTK has higher revenues than CKPT: CYTK (3.13M) vs CKPT (78K).
CKPTCYTKCKPT / CYTK
Capitalization149M6.18B2%
EBITDA-35.49M-459.67M8%
Gain YTD44.105-37.094-119%
P/E RatioN/AN/A-
Revenue78K3.13M2%
Total Cash4.95M1.06B0%
Total Debt2.47M790M0%
FUNDAMENTALS RATINGS
CKPT vs CYTK: Fundamental Ratings
CKPT
CYTK
OUTLOOK RATING
1..100
1861
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
10045
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3560
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CKPT's Valuation (86) in the Pharmaceuticals Major industry is in the same range as CYTK (100) in the Biotechnology industry. This means that CKPT’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (45) in the Biotechnology industry is somewhat better than the same rating for CKPT (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew somewhat faster than CKPT’s over the last 12 months.

CYTK's SMR Rating (100) in the Biotechnology industry is in the same range as CKPT (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew similarly to CKPT’s over the last 12 months.

CKPT's Price Growth Rating (35) in the Pharmaceuticals Major industry is in the same range as CYTK (60) in the Biotechnology industry. This means that CKPT’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for CKPT (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew significantly faster than CKPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CKPTCYTK
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 7 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
CKPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSCNX21.520.34
+1.61%
Natixis Vaughan Nelson Small Cap Value N
FSSZX39.550.59
+1.51%
Fidelity Advisor Stock Selector Sm Cp Z
ECEOX11.020.14
+1.29%
Lazard Emerging Markets Core Equity Open
RSIGX15.610.17
+1.10%
Victory RS International Y
SBMBX12.600.06
+0.48%
Saratoga Energy & Basic Materials A

CKPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CKPT has been loosely correlated with CYCC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CKPT jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CKPT
1D Price
Change %
CKPT100%
-5.44%
CYCC - CKPT
52%
Loosely correlated
-12.46%
CARA - CKPT
46%
Loosely correlated
-0.27%
GPCR - CKPT
43%
Loosely correlated
-1.11%
CYTK - CKPT
42%
Loosely correlated
+2.02%
AXON - CKPT
37%
Loosely correlated
+2.21%
More

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with KRON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then KRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
+2.02%
KRON - CYTK
43%
Loosely correlated
N/A
IOVA - CYTK
42%
Loosely correlated
+1.92%
DARE - CYTK
42%
Loosely correlated
+2.06%
CKPT - CYTK
41%
Loosely correlated
-5.44%
DSGN - CYTK
40%
Loosely correlated
+4.51%
More